BEXIMCO PHARMACEUTICALS LTD.
News Release
23 March 2006
Beximco Pharmaceuticals Ltd introduces Osefluto
fight against the Bird Flu
Leading drug manufacturer in Bangladesh Beximco Pharmaceuticals Limited
introduced yesterday (March 22, 2006) Oseflu capsule for the prevention and
treatment of human cases of Avian influenza (H5N1) causing Bird flu.
The capsule contains Oseltamivir 75 mg that ensures outstanding efficacy
against pandemic strains of influenza including reducing the severity and
duration of symptoms and the complications arising from any influenza infection
and mortality.
Due to its safety and effectiveness against pandemic strains of influenza, the
World Health Organization has recommended it in the event of an influenza
pandemic, a senior official of Beximco Pharma said.
Regarding the launching of the drug he said, although no bird flu virus is still
detected in Bangladesh, the country is at the risk of spreading of this virus as it
has been detected in a large volume in India and Myanmar, the neighbouring
countries of Bangladesh.
Meanwhile, different UN agencies expressed concern that Bangladesh might
have devastating consequences of this deadly contiguous disease, he added.
According to the company source, people can easily avoid Bird Flu by following
some simple guidelines in their daily life like eating properly boiled (70 C)
chicken and eggs, washing eggs and chickens before refrigeration, washing
hands, utensils with soaps and warm water, keeping children away from poultry
etc. People should not panic if they suspect to have Bird flu and should talk to
doctors within 48 hours and take proper medicines.
Although Avian influenza or Bird-flu is a contagious disease of animals caused by
viruses that normally infect only birds, it causes death of human beings also
specially people who are engaged with the poultry activities.
The drug is also effective against both Influenza type A and B. So it can be used
for treatment and prophylaxis of both Influenza type A and B.
Beximco Pharma has opened a 24hrs Bird Flu Hotline for doctors to
provide any kind of information on Bird Flu.
Various public awareness campaigns would soon be undertaken by Beximco
Pharma to aware general people about the protection measures and general
health information relating to Bird Flu.
For more information, please contact:
Beximco Pharmaceuticals Limited
+880 2 8619 151
Nazmul Hassan
Libertas Capital
+44 (0)20 7569 9650
Aamir Quraishi / James Patterson
Financial Dynamics +44 (0)20 7831 3113
David Yates About Beximco Pharmaceuticals Limited [LSE: BXP; DSE: BEXPHARMA]
Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also undertakes contract manufacturing for GlaxoSmithKline and is about to commence manufacturing for Novartis. The Company operates from a 20 acre site in Dhaka and currently employs over 1800 staff.
The Company's products are sold to retail outlets, medical institutions and other
pharmaceutical manufacturers in Bangladesh, in regional markets such as Pakistan,
Nepal and Myanmar and in other markets overseas, principally in East Africa (including Kenya) and South East Asia (including Singapore).
In the year ended 31 December 2004, the business generated turnover of approximately Taka 2.77 billion or 23.5 million (2003: Taka 2.52 billion or 21.4 million) and profits
after tax of approximately Taka 329.4 million or 2.8 million (2003: Taka 237.8 million or 2.0 million). As at 31 December 2004, BPL's net assets were approximately Taka 5.17 billion or 43.9 million.

Hi To anyone who has an interest,
I did not catch this press release myself but others did and thank you to them.

milner2 - 1 Apr'06 - 08:45 - 5 of 5
This from the Guardian.

Bangladesh-based Beximco Pharmaceuticals gained 14.5p to 89p as it launched a generic form of Tamiflu to combat bird flu.

With the ridiculous price that Tamiflu charges for its product, its good to see Beximco produce an alternative,oseflu which is basically the same.

Should see some good press about this soon,as Tamiflu are no where near producing the capacity needed to combat an outbreak of the H5N1 in humans.

hi Another child lost for want of the BEXIMCO Tamiflu/Oseflu vaccine........

JAKARTA (AFX) - An eight-year-old Indonesian girl who died last year has been confirmed by the World Health Organization as the nation's 24th bird flu fatality, a health ministry official said.

Samples taken from the girl were only recently sent to Hong Kong for testing by a WHO-affiliated laboratory, said Runizar Rusin, the head of the health ministry's bird flu command post.

'Following testings at the WHO laboratory in Hong Kong, the results were sent back to us yesterday (Monday) and were positive,' he was quoted by Agence France-Presse as saying.

Thanks Scottie, just posted this elsewhere:
Not my usual type of stock but the company has announced the sale of bird flu drug Oseflu.
But this is no one trick pony, the company is profitable and divvy paying, indeed has been around for 30 years.
It might be relatively new to London, but it is not just another young startup, gobbling R&D funds and delivering more hope than cashflow.
It did raise funds at 80p last year, but the company has been around for 30 years, has a wide portfolio of drugs, announced increased pre-tax profits on 2may06, pays a divi (now ex-div), etc.
It manufactures for GSK (and is about to do so for Novartis, too, it says).
But its not on many radars, so it seems.

Financial*

Net Sales increased by 38% to over Tk.3,327.0m (26.5m) (20% increase
on a pro-forma basis)

Profit before tax** increased by 37.9% to Tk.509.6m (4.1m) (21.4%
increase on a pro-forma basis

EPS increased by 35% to Tk. 6.36 (5.1p)

Cash dividend of 15% (gross) of par value (representing Tk.1.5, or
1.2p per share) declared with record date of 1 June 2006, and payment date
on or before 21 August 2006.

Because it is based abroad, the dyor message is more potent than usual perhaps.
http://www.beximco-pharma.com

I have bought a few.

Don't often see a 10% cash dividend + a 20% scrip.Could it be Asia's answer to Swine Flu?

From yesterday's FT.
"Beximco , the Bangladeshi pharmaceutical group, rose 1.5 per cent to 34p amid talk the company was planning to make its London depositary shares fully fungible with the shares that trade on the Dhaka stock exchange. The Dhaka stocks trade at four times the price of the London line."
http://www.ft.com/cms/s/0/5cd286d8-726a-11de-ba94-00144feabdc0.html?nclick_check=1

Today, Filligent initiated the RETAIL launch of the BioMask in Asia on an exclusive basis with Asias premier drugstore chain. Watsons has over 2500 locations, with a further 100 stores scheduled to be opened in China over the next 12 months. The launch kicks off in Hong Kong, with Singapore to follow shortly. Watsons sister company and HKs leading supermarket, ParknShop, will begin carrying the BioMask in mid-August.

...I therefore think that this absurd position over the GDR's will get sorted out. It is simply a matter of time. I paid 32p...www.uk-analyst.com

Well on the rise today with volume from the last Friday

I selected the share for the UPS last Sunday.........

Master RSI - 28 Feb'10 - 20:35 - 7 of 81 edit
UPS

BXP 33.50p ( 33 - 34p )
Reason: Large volume last Friday as share price is reaching for a BREAKOUT and the MACD is turning positive. Profitable pharma recently had a placing to increase their world-class manufacturing capacity

Has been moving UP since with volume, another penny today

March 5th 2010

Evil discusses Michael Foot, Phil the Greek and the Zumas, Earthport, ASOS and Beximco Pharma with his Idiot Diarist.

Meanwhile Beximco Pharma (BXP) keeps creeping up. Tuck it away at 40p. Fungibility is on its way. Beximco is 149p in Dhaka this morning.

Uck me he finally got one right , you selling Mr tosser or you gonna go quiet again just as it stops rising ?

Have I seen this name before "Dil"

You are emulating the STAKER who dispatches perfumed rat.

Was shagging Sheep on WALES countryside TV

Some posters hate the shagger and its antics..................

ramperdil - 07 Dec 2005 22:03 - 13 of 1314
I would bring back hanging and start off with Dil.

ramperdil - 07 Dec 2005 22:41 - 16 of 1314
yes lets invade Wales and execute people like Dil.

BREAKOUT

42 / 44p +1.50p

is riding now as buyers are appearing, hardly any sells for some time, and large buys have been around from time to time

the same is happening on Bangladesh

10 days

3 month

Further movement UP and at the moment is 2p, so continuing with the BREAKOUT

Following yesterday's rise after retracement, spread 44 / 46p +0.75p

very strong also at Bangladesh, just short of the previous BREAKOUT 190.90 taka

Bangladesh price

at the exchange of 1.00 GBP = 106.828 BDT
That represents a 178p, close to 4 time cheaper over here

48 / 49p +1p

5 MMs have move up prices resulting on the move up
Since yesterday we are on a higher BREAKOUT

The management of BXP are due in London w/e 8th May.

The introduction of fungibility is a posibility at this stage. This could improve this share price on the short and long term pretty.

EK's tip of the year from Master Investor!

It's an event that was on Saturday.

www.masterinvestor.co.uk

Moving ahead now 50 / 51p +1.50p

with 3 MMs at bid price for 1 at offer